II. Epidemiology
- Most common cause of premature Newborn Respiratory Distress
- Incidence: 40,000 infants annually in the United States
-
Prevalence varies by Gestational Age
- Gestational Age <28 weeks: Affects a majority of newborns
- Gestational Age 28-34 weeks: Affects <33% of newborns
- Gestational Age >34 weeks: Affects <5% of newborns
III. Pathophysiology
- Inadequate Pulmonary Surfactant (normally lowers alveolar surface tension)
- Leads to Atelectasis (increased alveolar surface tension, decreased compliance)
- Pulmonary vasculature responds with Vasoconstriction
- Lung hypoperfusion results in lung tissue ischemia
- Hyaline membranes form from epithelial cell destruction and infiltration of fluid and Protein
IV. Risk factors
- Immature lung development at delivery
- Premature Infant (see Prevalence based on Gestational Age above)
- Maternal Diabetes Mellitus (confers 6 fold increased risk)
- White race
- Family History of RDS in siblings
- Male gender
- Inadequate surfactant
- Cesarean birth without labor
- Premature Infant with perinatal asphyxia
- Antepartum Hemorrhage
- Second born Twin Gestation
V. Signs
- Timing
- Respiratory distress onset shortly after birth
- Progresses over first 12-48 hours
- Respiratory Distress Findings
- Tachypnea
- Nasal flaring
- Grunting
- Central Cyanosis
- Intercostal Muscle retractions
- Hypoxia
VI. Labs
- Antepartum Assessment
- Fetal Lung Maturity Assessment
- Newborn Assessment
- Blood Gas
- Swallowed Amniotic fluid Shake Test (historical use)
VII. Imaging: Chest XRay
- Findings appear within first 24 hours
- Hypoinflated lungs
- Homogenous opaque infiltrates (Reticulogranular pattern, "ground glass" appearance)
- Air Bronchograms (contrast of air-filled Bronchi against airless lung tissue)
VIII. Differential Diagnosis
IX. Management: General
- See Respiratory Distress in the Newborn
- See Newborn Resuscitation
-
Artificial Surfactant Replacement (Exosurf, Survanta)
- Surfactant delivery via Endotracheal Tube (200 mg/kg for initial dose)
- Followed by weaning Endotracheal Tube to N-CPAP
- Oxygen Delivery
- Body Temperature control
- Adequate hydration and nutrition
-
Neonatal Sepsis Evaluation
- Administer Antibiotics for 48 hours
X. Management: Continuous Positive Pressure Airway Pressure (CPAP)
- Indications
- FIO2 0.3 - 0.5 required to maintain PaO2 50-80 mmHg
- Delivery device
- No Abdominal Distention
- Abdominal Distention from hyperinflation
- Nasopharyngeal tube
- Endotracheal Tube
- Technique
- Starting Pressure: 5-7 cm H2O
- Titrate pressure by 1-2 cm H2O to PaO2 and effort
- Maintain Adequate Flow: 5-10 L/min
- Weaning
- Reduce FIO2 by 0.05 steps until FIO2 <0.40
- Reduce CPAP by 1-2 cm H2O (follow Arterial Blood Gas)
- Discontinue CPAP when pressure 4-6 cm H2O
XI. Management: Mechanical Ventilation
- Precautions
- Limit Mechanical Ventilation to shortest duration possible
- Prolonged Mechanical Ventilation is a risk for Bronchopulmonary Dysplasia (BPD)
- Indications
- Initial Respirator Settings
- Continuous-flow
- Pressure-limited
- Identify pressure settings with Anesthesia Bag
- Use manometer to measure pressures required
- Peak inspiratory pressure: 20-25 cm H2O
- Positive End-Expiratory Pressure (PEEP): 4-6 cm H2O
- Identify pressure settings with Anesthesia Bag
- Time-cycled
- Respiratory frequency: 20-30 breaths per minute
- Inspiratory duration: 0.4 to 0.6 second
- FIO2: 0.5 to 1.0
- Maintenance
- Maintain PaCO2: 45-60 mmHg
- Follow Arterial Blood Gas
- Every 4 to 6 hours
- Following every respirator setting change by 15 min
- Weaning
- Lower inspiratory pressure by 2 cm H2O steps to 30
- Lower FIO2 by steps of 0.05 to 0.5-0.6
- Lower inspiratory pressure by 1-2 cm H2O steps to 20
- Lower PEEP to 5 cm H2O
- Slowly decrease FIO2 to 0.40 in steps
- Lower respirator rate by 2-4 bpm steps to >8 bpm
XII. Prevention
- Prenatal Corticosteroids at 24-34 weeks gestation (up to 2 courses of steroid)
- See Preterm Labor Management
- Consider use up to <37 weeks in high risk patients
- Reduces Respiratory Distress Syndrome risk (NNT 11), and overall perinatal and neonatal death
- Effective for 7 days if given >24 hours before delivery
XIII. Complications: Short-term
- Air Leak
- Pneumothorax
- Pneumomediastinum
- Interstitial Emphysema
- Nosocomial Infection
- Intracranial Hemorrhage
-
Patent Ductus Arteriosus
- Associated with Pulmonary Hypertension
XIV. Complications: Long-term
-
Bronchopulmonary Dysplasia (BPD, 5-10%)
- Higher risk with prolonged Mechanical Ventilation
- Recurrent Wheezing through childhood and more complicated Asthma Exacerbations
- Retinopathy of Prematurity
- Neurologic Impairment
XV. References
- Cloherty (1991) Neonatal Care, Little Brown, 188-95
- Buel (2026) Am Fam Physician 113(1): 35-41 [PubMed]
- Hermansen (2007) Am Fam Physician 76(7):987-94 [PubMed]
- Hermansen (2015) Am Fam Physician 92(11):994-1002 [PubMed]